<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03023891</url>
  </required_header>
  <id_info>
    <org_study_id>161942</org_study_id>
    <secondary_id>5K23GM117395-03</secondary_id>
    <nct_id>NCT03023891</nct_id>
  </id_info>
  <brief_title>Pharmacogenomics of the Variability in the In Vivo Response to Glucocorticoids</brief_title>
  <official_title>Pharmacogenomics of the Variability in the In Vivo Response to Glucocorticoids</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Vanderbilt University Medical Center</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>National Institute of General Medical Sciences (NIGMS)</agency>
      <agency_class>NIH</agency_class>
    </collaborator>
  </sponsors>
  <source>Vanderbilt University Medical Center</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>Yes</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
    <is_us_export>No</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study evaluates the effect of acute administration of oral prednisone in white blood
      cells counts and glucose tolerance and the relationship of these measures with changes in
      gene expression in healthy volunteers. White blood cells counts, glucose tolerance and gene
      expression will be study before and after prednisone administration.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Prednisone is a potent anti-inflammatory drug that has large variability in its response. The
      large inter individual variability in the response to prednisone has a genetic component, but
      the genetic determinants of this variability remain unknown. We propose to use two relevant
      phenotypes, changes in white blood cell counts and changes in glucose tolerance induced by in
      vivo administration of prednisone, to characterize gene expression patterns and identify
      variants that are involved in the in vivo response to prednisone.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">February 15, 2017</start_date>
  <completion_date type="Anticipated">June 2019</completion_date>
  <primary_completion_date type="Anticipated">January 2019</primary_completion_date>
  <phase>Phase 1</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Other</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>white blood cell counts</measure>
    <time_frame>8 hours</time_frame>
    <description>changes from before drug to within 8 hours after drug administration</description>
  </primary_outcome>
  <primary_outcome>
    <measure>glucose tolerance</measure>
    <time_frame>8 hours</time_frame>
    <description>change from before drug to to within 8 hours after drug administration</description>
  </primary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">50</enrollment>
  <condition>Glucocorticoids Toxicity</condition>
  <condition>Glucose Intolerance</condition>
  <arm_group>
    <arm_group_label>Prednisone</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Each participant will received a single dose of oral 60 mg of prednisone</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Prednisone</intervention_name>
    <description>Prednisone 60 mg tablet once</description>
    <arm_group_label>Prednisone</arm_group_label>
    <other_name>generic, not applicable</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  18 to 45 years old (to exclude the effect of age on glucose tolerance);

          -  BMI between 20 and 25 kg/m2 (to exclude individuals that are likely to have impaired
             insulin response);

          -  Normal fasting glucose;

          -  Stable weight for three months before participation

        Exclusion Criteria:

          -  BMI &gt;25kg/m2;

          -  Fasting glucose â‰¥126 mg/dl

          -  Shift work or disordered sleep (to exclude individuals with alterations in the
             hypothalamus-adrenergic axis);

          -  Any diseases;

          -  Use of any medication regularly (including over-the-counter);

          -  Previous exposure to GCs (within the last year);

          -  Pregnancy
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>45 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Vivian K Kawai</last_name>
    <role>Principal Investigator</role>
    <affiliation>Vanderbilt University Medical Center</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Vivian Kawai</last_name>
    <phone>6153430041</phone>
    <email>vivian.k.kawai@vanderbilt.edu</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Annette Oeser, CCRP</last_name>
    <phone>6153223778</phone>
    <email>annete.oeser@vanderbilt.edu</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Vanderbilt University Medical Center -CRC</name>
      <address>
        <city>Nashville</city>
        <state>Tennessee</state>
        <zip>37203</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Annette Oeser, CCRP</last_name>
      <phone>615-322-3778</phone>
      <email>annette.oeser@vanderbilt.edu</email>
    </contact>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>June 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>January 12, 2017</study_first_submitted>
  <study_first_submitted_qc>January 13, 2017</study_first_submitted_qc>
  <study_first_posted type="Estimate">January 18, 2017</study_first_posted>
  <last_update_submitted>June 13, 2017</last_update_submitted>
  <last_update_submitted_qc>June 13, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">June 15, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Vanderbilt University Medical Center</investigator_affiliation>
    <investigator_full_name>Vivian Kawai</investigator_full_name>
    <investigator_title>Research Assistant Professor</investigator_title>
  </responsible_party>
  <keyword>glucocorticoids</keyword>
  <keyword>efficacy</keyword>
  <keyword>metabolic toxicity</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Glucose Intolerance</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Prednisone</mesh_term>
    <mesh_term>Glucocorticoids</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

